Logo
x

Search

Subscribe Now

Clover

Clover and Adimmune Enters into Exclusive Agreement to Commercialize AdimFlu-S (QIS) Influenza Vaccine in Mainland China

Clover and Adimmune Enters into Exclusive Agreement to Commercialize AdimFlu-S (QIS) Influenza Vaccine in Mainland China

  • February 20, 2023
Clover Reports the First Patient Dosing of SCB-2019 as a Heterologous Booster in P-III Trial for the Treatment of COVID-19

Clover Reports the First Patient Dosing of SCB-2019 as a Heterologous Booster in P-III Trial for the Treatment of COVID-19

  • June 14, 2022
Clover Initiates P-II Trial of COVID-19 Vaccine as Heterologous Booster for the Treatment of COVID-19

Clover Initiates P-II Trial of COVID-19 Vaccine as Heterologous Booster for the Treatment of COVID-19

  • November 29, 2021
PharmaShots Weekly Snapshot (February 01-05, 2021)

PharmaShots Weekly Snapshot (February 01-05, 2021)

  • February 5, 2021
Top COVID-19 Deals (Part II): Biopharma Vaccine Development

Top COVID-19 Deals (Part II): Biopharma Vaccine Development

  • May 1, 2020
PharmaShots Weekly Snapshot (February 24-28, 2020)

PharmaShots Weekly Snapshot (February 24-28, 2020)

  • March 2, 2020
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.